NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. 
INTRODUCTION
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia. IPF is a disease with poor prognosis and an aggressive nature, and poses major challenges to clinicians (1) (2) . Currently, no effective therapies exist to stop ongoing fibrosis in IPF.
Accumulation and persistence of myofibroblasts is believed to contribute to the development of fibrosis (3) . Alpha-smooth muscle actin ( -SMA) expression, increased proliferative capacity, and increased generation and secretion of the extracellular matrix (ECM) proteins such as collagen and fibronectin are key hallmarks of myofibroblast differentiation in fibrotic disorders (4) . It has been established that myofibroblast differentiation occurs through combinatorial signals involving TGF-1 and integrin signalling (5) .
Several studies suggest that oxidant-antioxidant imbalances in the lower respiratory tract play a significant role in the pathogenesis of IPF. Reactive oxygen species (ROS) can promote a profibrogenic environment in the lung through the modulation of the protease-antiprotease balance (6) . Also, ROS activate and/or mediate the effects of growth-regulatory cytokines, including TGF-1 (7) (8) . However, the endogenous sources of oxidants in IPF are poorly known.
The NADPH oxidases (NOX) proteins generate ROS, namely superoxide, by electron transfer to oxygen. Superoxide can be further converted to hydrogen peroxide by cellular superoxide dismutases. NADPH oxidases consist of membrane-associated and cytosolic subunits (for review, see reference (9)). The most thoroughly investigated NADPH oxidase is the phagocytic gp91 phox (NOX2)-containing subunit that interacts with a second membrane bound subunit, p22 phox , and several cytosolic and regulatory subunits including p47 phox , p67 phox , and
Rac. Both NOX1 and NOX4 are homologs of NOX2, and are expressed in different nonphagocytic cells (9) . It has been recently shown that NOX1 and NOX4 are expressed in pulmonary arterial adventitial fibroblasts and that NOX4 contributes to the increase in ROS generation under hypoxic conditions, stimulating proliferation and inhibiting apoptosis of these cells (10) . Furthermore, NOX4 is involved in TGF-1-induced human cardiac fibroblast differentiation into myofibroblasts (11) . Therefore, we hypothetized that NOX1 and NOX4
could be also expressed in parenchymal pulmonary fibroblasts and could mediate the effects of TGF-1.
The aim of this study was to investigate NOX1 and NOX4 expression in pulmonary fibroblasts from control subjects and IPF patients and to analyse their respective role in mediating TGF-1-induced fibroblast differentiation into myofibroblast, a key phenomenon in IPF pathogenesis (12) . The myofibroblast phenotype was analyzed by examining -SMA and procollagen I ( 1) expression.
MATERIAL AND METHODS
See online supplement for further details.
Lung fibrosis patients
Fibroblasts were derived from lung tissue sampled from 8 IPF patients. Lung samples were obtained by open lung biopsy (n=4) or at the time of lung transplantation (n=4). IPF was diagnosed according to the ATS-ERS consensus criteria (17) . Patients (6 males; 2 females) had a median age of 50 years [range, 44 to 69 yr]. 6 were ex-smokers, 1 never smoked and 1
was an active smoker. At the time of lung sampling, 3 patients were treated with low dose oral corticosteroids, associated with azathioprin in one patient.
Control patients
Fibroblasts were derived from lung samples from 9 patients (6 males, 3 females) undergoing lung surgery for removal of a primary lung tumor. Normal lung was obtained from a noninvolved segment, remote from the solitary lesion. Median age was 54 years [28 to 68] .
Two patients had never smoked, 4 were ex-smokers and 3 were active smokers.
Culture of fibroblasts
Human lung fibroblasts were cultured from lung explants until passage 5 as previously described (13) . In some experiments, cells were incubated in the presence of TGF-1 (10 ng/ml, R&D Systems, Lille, France) or vehicle.
Cellular Toxicity
Cellular toxicity and viability were assessed by trypan blue exclusion and lactate dehydrogenase (LDH) release in the medium, as described previously (14) .
Intracellular ROS production
Intracellular ROS production was quantified by measuring H 2 -DCFH-DA oxidation, as described previously (14) (15) . Results are expressed in fluorescent arbitrary units. 
Real-time RT-PCR

Cell transfection with siRNA
To suppress endogenous NOX4 expression, experiments involved a specific siRNA (Xeragon-Qiagen, Valencia, CA,) against NOX4 designed on the target region from the NOX4 gene (5'-AAACCGGCAGGAGUUUACCCAG-3'). Scrambled siRNA (nonhomologous to the human genome, 5'-AACCAGCAAGGUGUAUCGCCAC-3') was used as a control.
Western blot analysis
Western blot was performed as described previously (16) 
Cell migration assay
Cell motility was examined as previously described (17) using a modified Boyden chamber apparatus (Transwell Costar) in response to 24 h stimulation with rhPDGF-BB 10ng/ml (R&D systems) or media alone. Chemotactic index was determined as the ratio of cells moving in response to a chemoattractant relative to cells moving in response to media control.
Immunohistochemical analysis
Immunohistochemistry was performed as previously described (16 
Statistical analysis
All the data are displayed as medians, interquartile range and minimum and maximum values.
All of the analysis were performed by non-parametric tests. p<0.05 was considered as statistically significant.
RESULTS
Expression of NOX mRNA and oxidants production in pulmonary fibroblasts
Lung fibroblasts from control patients expressed NOX1, 2, 4 and 5 mRNA at similar degrees, 
Expression of markers of myofibroblast diferentiation
The content of -SMA mRNA was increased in IPF fibroblasts as compared to controls 3D) .
Role of NOX4 on TGF-1 induced myofibroblast differentiation
We first examined if ROS, the product of NOX4 activity, were involved on TGF-1 induced myofibroblast differentiation. First, we examined the effect of the antioxidant Nacetylcystein. Pretreatment of control and IPF fibroblasts for 1 h with N-acetylcysteine (1 mM) totally prevented the increase of -SMA and procollagen I ( 1) mRNA expression induced by TGF-1 ( fig 3A, B and C) . This result strongly suggested that the oxidantantioxidant imbalance is involved in the effect of TGF-1.
In order to examine the involvement of NOX4 on TGF-1 effects, we first incubated the fibroblasts for 1 h with diphenylene iodonium (DPI, 10 M), an inhibitor of flavoproteindependent oxidases including NOX (18) . DPI prevented TGF-1 induced -SMA and procollagen I ( 1) mRNA expression in both control and IPF fibroblasts ( fig 3A, B and C) .
Second, we examined the effects of cell transfection with a NOX4 siRNA. NOX4 siRNA significantly reduced NOX4 mRNA levels at 24 h in both control and IPF fibroblasts whereas no such effect was observed with lipofectamine or scrambled siRNA (fig 4A and B) .
Transfection with NOX4 siRNA significantly inhibited the effect of TGF-1 on myofibroblats differentiation in both control and IPF cells (fig 4A and B) . Indeed, expression of -SMA and procollagen I ( 1) were reduced by 67% and 68% and by 64% and 54% in control and IPF fibroblasts respectively. These results demonstrate that NOX4 mediates the effect of TGF-1 on myofibroblast differentiation.
It has to be noted that both N-acetylcysteine and DPI reversed NOX4 mRNA induction by TGF-1, showing probably an autocrine role of NOX4-derived ROS on NOX4 induction by TGF-1.
None of the different pharmacological treatments and transfection procedures altered cell viability (data not shown).
Role of NOX4 on TGF-1 induced SMAD 2 and 3 phosphorylation
It has been shown that Smads mediate TGF-ß1 induction of -SMA in human lung fibroblasts 5A and B) . These results demonstrate that NOX4-produced ROS are involved in Smad2/3 phosphorylation by TGF-1. (21) in an article published after the present study was submitted for publication.
Role of NOX4 on PDGF induced fibroblast migration
Expression of NOX4 in control fibroblasts
Expression of NOX4 protein was detected in lungs from both control subjects and patients with idiopathic pulmonary artery hypertension, the expression was predominantly in the medial layer of pulmonary arteries and was higher in patients than in controls (10).
Accordingly, pulmonary artery adventitial fibroblasts in culture also expressed both NOX1
and NOX4 (22) . In agreement with these findings, in the present study we found that parenchymal pulmonary fibroblasts from control and IPF patients expressed both NOX1 and NOX4. This result is different from data reported in cardiac fibroblasts in which NOX1 expression was barely detectable (11) , stressing the cell specificity of NOX expression. To the best of our knowledge this is the first demonstration that non-vascular pulmonary fibroblasts express NOX. It is noteworthy that our experiments were performed on cells in the fifth passage, since progressive down-regulation of NOX4 expression has been correlated with increasing passage number (23) . However, our immunohistochemical results demonstrate that fibroblasts do express immunoreactive NOX-4 in situ in the fibrotic lung.
NOX4 up-regulation in IPF fibroblasts
The mechanism(s) involved in NOX4 up-regulation in IPF fibroblasts are difficult to analyze since very few data concerning the regulation of NOX4 activity and expression are available.
Recent data from recombinant NOX4 expression suggest that NOX4 enzymatic activity depends on the membrane-associated p22 phox subunit, whereas cytosolic subunits, phosphorylation, or interaction with Rac are apparently not required for its activation (24) (25) . Concerning the regulation of gene expression, and the relevant transcription factors involved, very few data are available since promoter studies of NOX4 are lacking. Our data clearly show that TGF-1 increases NOX4 expression both in control and in IPF fibroblasts, in accordance with previous data in cardiac fibroblasts and airway smooth muscle (11) (26) (27) . Interestingly, the increase was stronger in IPF fibroblasts than in controls. One can speculate that TGF-1 can be responsible of NOX4 up-regulation in IPF fibroblasts ex vivo via an autocrine loop since expression of TGF-1 has been shown to be increased in these cells (28) . Furthermore, high levels of TGF-1 produced by epithelial cells could contribute to up-regulation in fibroblasts in situ in the lung of IPF patients (29) .
NOX4 induction by TGF-1 was inhibited by N-acetylcysteine and DPI suggesting that NOX-produced ROS are implicated in NOX4 gene expression regulation. We obtained similar results in human alveolar bronchiolar and epithelial cell lines (14) , but the molecular mechanisms involved are unknown. Clearly, more studies are needed to understand NOX4 gene expression regulation in IPF fibroblasts.
Role of NOX4 on myofibroblasts differentiation in IPF
Whatever the mechanism(s) involved in gene expression regulation, NOX4 was involved in myofibroblast differentiation in IPF. This conclusion is supported by 1) the correlation between basal NOX4 and -SMA and procollagen I ( 1) mRNA expression, and 2) the prevention of TGF-1 differentiating effects by the NOX4 siRNA. This last phenomenon was also observed in cardiac fibroblasts (11) . It has to be noted that we can not ensure that NOX4-produced ROS were involved in myofibroblats differentiation in the present study since we did not measure fibroblast ROS production in NOX4 siRNA treated cells. However, several experimental evidences strongly suggest that the effects we observed were mediated by ROS produced by NOX4. First, NOX4 was the only NOX homolog up regulated in IPF fibroblasts; second, ROS production was higher in these cells as compared to control cells, and third similar results in terms of -SMA and procollagen I ( 1) expression were obtained by incubating these cell with the antioxidant NAC and by transfecting them with a NOX4
siRNA. Furthermore, a recent study with controlled recombinant expression of NOX4 demonstrated a strong correlation between NOX4 mRNA level and ROS generation (30).
Thus, in this experimental setting, the activity of NOX4 was demonstrated to depend directly on its gene expression levels. Moreover, we and others have previously shown that siRNA against NOX4 reduced basal ROS level in rat smooth muscle cells and in pulmonary epithelial cell lines significantly (14) (31) . Collectively, these data strongly support a role of NOX4-produced ROS on myofibroblast differentiation.
Interestingly, immunohistochemistry showed a strong expression of NOX4 by hyperplastic alveolar epithelium in the fibrotic lung (fig 2) . In the kidney, NOX4 has been involved in the regulation of epithelial-mesenchymal transition (32) . Although not specifically studied, this phenomenon could also occur in the lung and implicate NOX4 in the fibrogenic process through multiple ways.
Role of NOX4 on TGF-1 induced myofibroblasts differentiation and PDGF-induced migration
TGF-ß1 stimulates differentiation of fibroblasts into myofibroblasts using Smad 2/3 signalling (20) . After initial phosphorylation, Smad 2/3 activation in response to TGF-ß1 is prolonged (hours to days depending on the cell type). Interestingly, we showed that Smad 2/3 phosphorylation was up-regulated by TGF-1 after 18 h of incubation. The antioxidant Nacetylcysteine, the NOX inhibitor DPI, and the siRNA anti NOX4 lead to a marked inhibition of Smad2/3 phosphorylation, as demonstrated previously in human cardiac fibroblasts (11) .
These data imply that oxidants produced by NOX4 mediate -SMA and procollagen I ( 1) upregulation in pulmonary fibroblasts in response to TGF-ß1 probably by stimulating phosphorylation and activation of Smads 2/3. In addition, NOX4 mediates PDGF-induced fibroblasts migration.
In summary, we have shown NOX4 upregulation in pulmonary fibroblasts from IPF patients, and identified a novel role for NOX4 as essential mediator of Smad2/3 transcription factor activation in response to TGF-ß1 in pulmonary fibroblasts. Because of the critical role of TGF-ß1-induced myofibroblast activation in IPF, these data provide insight into novel mechanisms with potential therapeutic implications for IPF.
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